Rejected from JBC? Choose the Next Journal

JBC's 2026 scope statement keeps rigorous molecular and biochemical insight at the center while recognizing that conceptual advances, new frameworks, integrative analyses, computation, structural biology, and large-scale approaches can generate that insight. It also says purely descriptive, biologically ungrounded correlation and incremental work remain outside scope.

Diagnose whether the JBC rejection is about insight, causality, or evidence validity.

A desk rejection can concern conceptual reach, priority, fit, article form, or an opening that does not make the molecular insight visible. It is not a technical certification. If the work is a valuable dataset or application without a general molecular result, choose a journal that values that object.

A post-review rejection is portable. Concerns about antibody specificity, inhibitor selectivity, construct artifacts, dose, timing, sample independence, missing rescue, image handling, statistical units, model relevance, or unavailable data will follow the manuscript.

A transfer option is administrative. Inspect the receiving journal's scope and evidence expectations, replace files when permitted, and never treat transfer as an acceptance signal.

Biochemical Journal

Best for: a manuscript whose durable value is a rigorous molecular mechanism across biochemistry, cellular bioscience, signaling, metabolism, or disease.

Think twice if: the work remains observational or the causal bridge is missing. The official scope emphasizes work beyond observation, so make perturbations, controls, orthogonal evidence, and replicability explicit.

The FEBS Journal

Best for: a significant molecular or cellular advance with broad biological interest, supported by modern experimental evidence and a clear conceptual result.

Think twice if: the contribution is narrow, incremental, or lacks biological insight. The official scope says computational, modeling, or structural studies of specific systems should include experimental data.

Journal of Molecular Biology

Best for: molecular structure, dynamics, interactions, assembly, computation, or mechanism as the center of the paper.

Think twice if: descriptive omics is the main result or structural and functional datasets never constrain the same model. Integrate biophysical evidence with a tested molecular consequence.

Molecular & Cellular Proteomics

Best for: proteomic measurement, analysis, standards, resource value, or a proteomics-enabled biological discovery that substantially advances the field.

Think twice if: proteomics is only a supporting assay for another biological story. Show identification quality, false-discovery control, quantification, missingness, batch handling, validation, and data access.

FEBS Letters

Best for: a concise, timely, and complete molecular-bioscience finding whose central result can be supported without a sprawling narrative.

Think twice if: the manuscript needs an extensive unresolved experiment program. Shorter form does not mean incomplete evidence; remove claims that cannot be proved and support the remaining result cleanly.

iScience

Best for: complete interdisciplinary work connecting molecular biology with computation, materials, engineering, medicine, or another field where the combined evidence is the contribution.

Think twice if: broad scope is being used to avoid weak causality or reproducibility. Keep the validity checks of every contributing discipline intact and explain the cross-field information gain.

For every abstract and figure-level claim, record the experiment that supports it, the unit of inference, the strongest alternative explanation, the control that addresses it, and the result that would falsify the model.

Appeal only around a material factual or procedural error: a report relies on the wrong construct, overlooks a supplied control, or evaluates a claim the manuscript does not make. Identify the exact evidence and possible effect. Disagreement about significance is usually better handled by revision.

Use a transfer when the receiving scope fits the revised center and the administrative benefit matters. Confirm whether reports transfer and whether the scientific record can be replaced.

Submit fresh after closing the prior process when the revision changes the biological contract or audience. Never submit the manuscript to another journal in parallel.

In our pre-submission review work with JBC manuscripts, we trace every abstract claim through methods, reagents, controls, raw images, statistical analysis, result figures, supplementary evidence, and the data availability record. These are qualitative manuscript-review patterns, not claims about JBC's private editorial decisions or acceptance rate.

Pattern 1: one reagent carries the mechanism

In JBC candidates, an inhibitor, antibody, guide, or overexpression construct often produces the central phenotype while specificity is assumed. We check target engagement, dose, off-targets, construct sequence, rescue, independent reagents, and orthogonal readouts. We then revise the methods and figure legends so the validity evidence is inspectable. The mechanism often narrows or becomes much stronger.

Pattern 2: representative images replace inference

Another JBC pattern shows compelling microscopy fields or blots without defining selection, biological replication, normalization, exclusions, or uncertainty. We return to raw images and instrument files, predefine inclusion, quantify all eligible units, and model nested experiments correctly. We compare uncropped source data with every result figure. The visual story must agree with the statistical one.

Pattern 3: correlation is narrated as a pathway

In JBC manuscripts, two signals may move together after treatment while the discussion inserts a causal arrow. We test temporal order, direct interaction, necessity, sufficiency, rescue, dose response, and competing pathways. We make the abstract and conclusion distinguish direct evidence from interpretation. If the arrow remains untested, the claim becomes a model rather than a demonstrated mechanism.

Pattern 4: biological importance outruns the model

The final JBC pattern generalizes a result from one transformed line or supraphysiological condition to organismal disease. We inspect endogenous expression, dose, timing, culture context, sample size, and model provenance, then add relevant cells, primary material, or an in vivo model where feasible. Otherwise we state the actual system throughout the title, discussion, and conclusion and route to a methods or molecular audience.

Choose the next journal only when the revised abstract can identify the molecular question, causal intervention, assay-validity controls, orthogonal evidence, biological context, insight, and boundary. Verify current scope, article type, data policies, fees, and author instructions immediately before submission.

Read final Search Console data after 14 complete days. At 21 complete days, keep, revise, consolidate, or stop based on indexation, exact-owner impressions, clicks, query fit, and qualified /ai-review starts.